A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

NCT00830869 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Non-hematologic Malignancies

Interventions

DRUG: IXAZOMIB

Sponsor

Millennium Pharmaceuticals, Inc.